EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 13

Perilla Perilla frutescens (L.) Britton

Also called: shiso, Japanese basil, purple perilla, perilla seed oil

Perilla is an annual herb of the mint family (Lamiaceae) native to Asia. Two different materials are studied: leaf and other extracts or leaf powder, containing rosmarinic acid and flavonoids, and seed oil, rich in the omega-3 fatty acid alpha-linolenic acid.

Category
Botanical
Part used
Leaf (extract or powder); seed (oil)
Strongest evidence
C Limited
Native range
Native from the southern Russian Far East to Pakistan (POWO: "S. Russian Far East to Pakistan"; native list includes China, Japan, Korea, India and mainland Southeast Asia); introduced in parts of North America and Europe
Reviewed
2026-10-30

Class 2 Moderately studied in people. No review stating a count was found. Nine randomized controlled trials of perilla alone versus placebo (an olive-oil placebo in one) were opened: five of extracts or leaf powder (sources [1]–[5]) and four of seed oil (sources [7]–[10]). [1]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

7 topics studied5 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Perilla does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Perilla, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Rosmarinic acid-enriched extract: seasonal allergic rhinoconjunctivitisCIn a 21-day RCT of 29 patients with mild symptoms, a rosmarinic acid-enriched perilla extract (50 or 200 mg) raised responder rates for itchy nose and eyes and watery eyes versus placebo. [1]
Leaf extract: gastrointestinal discomfortCIn a 4-week pilot RCT of 50 adults, symptoms improved within the perilla group; versus placebo, only a combined bloating and discomfort score in women differed significantly. [2]
Extract (var. frutescens): mild knee joint painCIn an 8-week RCT of 80 adults without radiographic arthritis, a 700 mg extract capsule twice daily reduced pain and WOMAC scores more than placebo; inflammation markers did not change. [3]
Leaf extract: cognitive impairmentCIn a 12-week RCT of 100 adults, 500 mg/day of a purple perilla leaf ethanol extract improved cognitive test scores versus placebo; blood amyloid and BDNF did not differ. The extract maker funded the study. [4]
Leaf powder: blood pressure and oxidized LDLCIn a 6-month RCT of 60 healthy adults, leaf powder lowered oxidized LDL; home systolic pressure fell more than placebo only in those with prehypertension. [5]
Seed oil: cognition in mild to moderate dementiaXIn a 6-month add-on RCT (182 completers), perilla seed oil did not improve cognitive function versus placebo; total and LDL cholesterol were lower. [10]
Seed oil: bone measures in middle-aged adultsCIn a 12-month RCT of 52 adults, 7.0 ml/day perilla seed oil raised a heel-ultrasound bone score and lowered a bone-resorption marker versus olive oil. [7]

Main constituents: Extracts: rosmarinic acid, a polyphenol (an extract enriched for it was studied) [1]; Water extract of dried leaves: about 10 flavonoids, notably vicenin-2 (apigenin-6,8-di-C-glycoside), with caffeic acid and rosmarinic acid [2]; Seed oil: alpha-linolenic acid, a plant omega-3 fatty acid [7]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Extract enriched for rosmarinic acid: 50 or 200 mg daily for 21 days. [1]
  • Extract (var. frutescens): one 700 mg capsule, containing 486 mg extract, twice daily for 8 weeks. [3]
  • Seed oil: 7.0 ml daily for 12 months. [7]
  • Seed oil: 4.8 g per day for 8 weeks. [8]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • In the 21-day extract trial, patients reported no adverse events and routine blood tests showed no significant abnormalities. [1]
  • In the 8-week knee trial, all adverse events were minor and considered unlikely to result from the extract. [3]
  • In the 6-month dementia trial, perilla seed oil had no adverse effect on kidney, liver, blood components or glucose metabolism. [10]
Quality

Identity, quality and standardization

  • Seed oil is studied as a rich source of the omega-3 fatty acid alpha-linolenic acid. [7]
  • A studied water extract of dried leaves was characterized by an HPLC fingerprint of about 10 flavonoids, caffeic acid and rosmarinic acid. [2]
Regulation

Regulatory status

  • US: by law, FDA does not approve dietary supplements or their labeling before they are marketed. [12]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Rosmarinic acid (extracts) Phenolic acids (caffeic acid ester) [P1]
  • Alpha-linolenic acid (seed oil) Omega-3 fatty acids [P2]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming perilla (Perilla frutescens) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P5]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC evaluation of perilla (Perilla frutescens) was found (IARC Monographs list of classifications, Volumes 1-142, checked 2026-10-29). [P7]
  • No NTP technical report on perilla (Perilla frutescens) was found (NTP technical reports list checked 2026-10-29). [P8]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each dietary-ingredient component — US cGMP rule for dietary supplements: at least one appropriate test or examination must verify the identity of any component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)); exemption only through a petition FDA grants (111.75(a)(1)(ii)). [P6]

Supply and conservation

  • IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29. [P9]

Absorption in people

  • Extract: after a single dose providing 200 mg rosmarinic acid in six healthy men, rosmarinic acid, methyl-rosmarinic acid and ferulic acid appeared in plasma (peaks at 0.5, 2 and 0.5 h), mostly as conjugates; 6.3% of the dose was excreted in urine, about 75% of it within 6 h. [P3]
  • Seed oil: in 12 healthy adults given single 6 g doses, enteric-coated and uncoated perilla seed oil formulations showed no difference in plasma alpha-linolenic acid pharmacokinetics over 0-24 h. [P4]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. Takano H, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood) 2004;229(3):247-54 (PMID 14988517), 2004-03. pubmed.ncbi.nlm.nih.gov
  2. Matsuzaki K, et al. Perilla seed oil improves bone health by inhibiting bone resorption in healthy Japanese adults: a 12-month, randomized, double-blind, placebo-controlled trial. Phytother Res 2023;37(6):2230-2241 (PMID 36637040), 2023-06. pubmed.ncbi.nlm.nih.gov
  3. Baba S, et al. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur J Nutr 2005;44(1):1-9 (PMID 15309457), 2005-02. pubmed.ncbi.nlm.nih.gov
  4. Kurowska EM, Dresser GK, Deutsch L, Vachon D, Khalil W. Bioavailability of omega-3 essential fatty acids from perilla seed oil. Prostaglandins Leukot Essent Fatty Acids 2003;68(3):207-12 (PMID 12591004), 2003-03. pubmed.ncbi.nlm.nih.gov
  5. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  7. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1-142 (last updated 2026-07-23; checked 2026-10-29), 2026-07-23. monographs.iarc.who.int
  8. National Toxicology Program (NIEHS). Technical Reports list, TR-001 to TR-606 (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  9. GBIF species API: IUCN Red List category for Perilla frutescens (L.) Britton, 2026-10-29. api.gbif.org
Sources

Sources

  1. Takano H, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood) 2004;229(3):247-54 (PMID 14988517), 2004-03. pubmed.ncbi.nlm.nih.gov
  2. Buchwald-Werner S, Fujii H, Reule C, Schoen C. Perilla extract improves gastrointestinal discomfort in a randomized placebo controlled double blind human pilot study. BMC Complement Altern Med 2014;14:173 (PMID 24885816; full text PMC4038823), 2014-05-27. pmc.ncbi.nlm.nih.gov
  3. Kim N, et al. Efficacy of Perilla frutescens (L.) Britton var. frutescens extract on mild knee joint pain: a randomized controlled trial. Front Pharmacol 2023;14:1114410 (PMID 36998613; full text PMC10043449), 2023-03-14. pmc.ncbi.nlm.nih.gov
  4. Baek HI, et al. Efficacy and safety of standardized ethanol extract of purple perilla (Perilla frutescens Britton var. acuta Kudo) leaves in cognitive impairment: a randomized, double-blind, placebo-controlled clinical trial. Nutrients 2026;18(6):960 (PMID 41901135), 2026-03-18. pubmed.ncbi.nlm.nih.gov
  5. Hashimoto M, et al. Intake of alpha-linolenic acid-rich Perilla frutescens leaf powder decreases home blood pressure and serum oxidized low-density lipoprotein in Japanese adults. Molecules 2020;25(9):2099 (PMID 32365849), 2020-04-30. pubmed.ncbi.nlm.nih.gov
  6. Baba S, et al. Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans. Eur J Nutr 2005;44(1):1-9 (PMID 15309457), 2005-02. pubmed.ncbi.nlm.nih.gov
  7. Matsuzaki K, et al. Perilla seed oil improves bone health by inhibiting bone resorption in healthy Japanese adults: a 12-month, randomized, double-blind, placebo-controlled trial. Phytother Res 2023;37(6):2230-2241 (PMID 36637040), 2023-06. pubmed.ncbi.nlm.nih.gov
  8. Lee S, et al. Effects of perilla oil on platelet and inflammatory responses in healthy smokers: a randomized, double-blind, placebo-controlled, parallel trial. Food Funct 2026;17(12):5394-5409 (PMID 42132779), 2026-06-22. pubmed.ncbi.nlm.nih.gov
  9. Kawamura A, Nemoto K, Sugita M. Effect of 8-week intake of the n-3 fatty acid-rich perilla oil on the gut function and as a fuel source for female athletes: a randomised trial. Br J Nutr 2023;129(6):981-991 (PMID 35705194), 2023-03-28. pubmed.ncbi.nlm.nih.gov
  10. Kamalashiran C, et al. Outcomes of perilla seed oil as an additional neuroprotective therapy in patients with mild to moderate dementia: a randomized control trial. Curr Alzheimer Res 2019;16(2):146-155 (PMID 30543172), 2019. pubmed.ncbi.nlm.nih.gov
  11. Kurowska EM, Dresser GK, Deutsch L, Vachon D, Khalil W. Bioavailability of omega-3 essential fatty acids from perilla seed oil. Prostaglandins Leukot Essent Fatty Acids 2003;68(3):207-12 (PMID 12591004), 2003-03. pubmed.ncbi.nlm.nih.gov
  12. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  13. Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data. Perilla frutescens (L.) Britton (accessed 2026-10-29), 2026-10-29. powo.science.kew.org
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.